NCT04853576: A Study Evaluating the Safety and Efficacy of EDIT-301 in Participants With Severe Sickle Cell Disease (RUBY)
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 45 planned
- Started
- 4 May 2021
- Primary completion
- Aug 2025
- Arms
- EDIT-301
- Results
- None posted
- 21 Apr 2021: Trial registered
- 4 May 2021: Trial started